BMH BRÄUTIGAM advises Caspar Health on approximately € 5 m. financing round
BMH BRÄUTIGAM has advised the Berlin eHealth company Caspar Health in the context of the recently concluded financing round in the amount of € 5.3 m.
The young company, founded by Maximilian Michels, Benjamin Pochhammer and Maximilian Wadenfels , offers medical institutions the opportunity to provide their patients with digital therapy, i.e. independent of time and place and beyond the hospital stay. This digital form of therapy has been approved by several pension insurance institutions in the fields of rehabilitation, prevention and aftercare and is already being used by more than 100 clinics.
With the fresh capital, Caspar Health intends to further expand its market leadership in Germany in the field of digital therapy. To this end, the product in particular is to be developed further and new care models for clinics and their patients are to be created. In addition to the existing investors Atlantic Labs, Think.Health Ventures and Helmut C. Nanz, new investor Ananda Impact Ventures also participated in the financing round as lead investor.
Background: The contact to Caspar Health was established through recommendations from the market.
Team BMH BRÄUTIGAM: Dr. Patrick Auerbach-Hohl, Dr. Alexander Wulff, Janina Erichsen (all Venture Capital)